Cite
Liquiritin exhibits anti-acute lung injury activities through suppressing the JNK/Nur77/c-Jun pathway.
MLA
Zhou, Hongling, et al. “Liquiritin Exhibits Anti-Acute Lung Injury Activities through Suppressing the JNK/Nur77/c-Jun Pathway.” Chinese Medicine, vol. 18, no. 1, Apr. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s13020-023-00739-3.
APA
Zhou, H., Yang, T., Lu, Z., He, X., Quan, J., Liu, S., Chen, Y., Wu, K., Cao, H., Liu, J., & Yu, L. (2023). Liquiritin exhibits anti-acute lung injury activities through suppressing the JNK/Nur77/c-Jun pathway. Chinese Medicine, 18(1), 1–12. https://doi.org/10.1186/s13020-023-00739-3
Chicago
Zhou, Hongling, Tangjia Yang, Zibin Lu, Xuemei He, Jingyu Quan, Shanhong Liu, Yuyao Chen, et al. 2023. “Liquiritin Exhibits Anti-Acute Lung Injury Activities through Suppressing the JNK/Nur77/c-Jun Pathway.” Chinese Medicine 18 (1): 1–12. doi:10.1186/s13020-023-00739-3.